Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.65 |
| ▸ | NTSR2 | O95665 | 6/20 | 0.59 |
| ▸ | NTSR1 | P30989 | 6/20 | 0.59 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30353452 | 0.97 | OPRM1 (0.62) | OPRM1NTSR2NTSR1SORT1SLC6A2 | |
| SCHEMBL30273400 | 0.94 | OPRM1 (0.64) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL30497929 | 0.90 | OPRM1 (0.64) | OPRM1OPRD1SLC6A2F2 | |
| Lysine SCHEMBL185235 | 0.89 | OPRM1 (0.66) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31114383 | 0.88 | OPRM1 (0.68) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31679387 | 0.88 | OPRM1 (0.66) | OPRM1OPRD1SLC6A2F2 | |
| SCHEMBL31114332 | 0.87 | OPRM1 (0.70) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31114390 | 0.87 | OPRM1 (0.64) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31114540 | 0.87 | OPRM1 (0.64) | OPRM1NTSR2NTSR1SORT1OPRD1 | |
| SCHEMBL31114066 | 0.87 | OPRM1 (0.64) | OPRM1NTSR2NTSR1SORT1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |